Завершено
Фаза II
Россия
MIR 19 ® · National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia
Open Multicenter Controlled Clinical Trial to Evaluate Safety and Efficacy of Aerosolized MIR 19 ® Inhalation in Patients With Moderate COVID-19 Who Did Not Require Treatment in the Intensive Care Unit.